IBDEI07C ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9611,1,3,0)
 ;;=3^TBI-Open Wound,No LOC
 ;;^UTILITY(U,$J,358.3,9611,1,4,0)
 ;;=4^854.01
 ;;^UTILITY(U,$J,358.3,9611,2)
 ;;=^274712
 ;;^UTILITY(U,$J,358.3,9612,0)
 ;;=854.02^^63^614^118
 ;;^UTILITY(U,$J,358.3,9612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9612,1,3,0)
 ;;=3^TBI-Open Wound,LOC < 1hr
 ;;^UTILITY(U,$J,358.3,9612,1,4,0)
 ;;=4^854.02
 ;;^UTILITY(U,$J,358.3,9612,2)
 ;;=^274713
 ;;^UTILITY(U,$J,358.3,9613,0)
 ;;=854.03^^63^614^117
 ;;^UTILITY(U,$J,358.3,9613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9613,1,3,0)
 ;;=3^TBI-Open Wound,LOC 1-24hr
 ;;^UTILITY(U,$J,358.3,9613,1,4,0)
 ;;=4^854.03
 ;;^UTILITY(U,$J,358.3,9613,2)
 ;;=^274714
 ;;^UTILITY(U,$J,358.3,9614,0)
 ;;=854.04^^63^614^119
 ;;^UTILITY(U,$J,358.3,9614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9614,1,3,0)
 ;;=3^TBI-Open Wound,LOC > 24hr
 ;;^UTILITY(U,$J,358.3,9614,1,4,0)
 ;;=4^854.04
 ;;^UTILITY(U,$J,358.3,9614,2)
 ;;=^274715
 ;;^UTILITY(U,$J,358.3,9615,0)
 ;;=854.11^^63^614^114
 ;;^UTILITY(U,$J,358.3,9615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9615,1,3,0)
 ;;=3^TBI-Closed Wound,No LOC
 ;;^UTILITY(U,$J,358.3,9615,1,4,0)
 ;;=4^854.11
 ;;^UTILITY(U,$J,358.3,9615,2)
 ;;=^274721
 ;;^UTILITY(U,$J,358.3,9616,0)
 ;;=854.12^^63^614^113
 ;;^UTILITY(U,$J,358.3,9616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9616,1,3,0)
 ;;=3^TBI-Closed Wound,LOC < 1hr
 ;;^UTILITY(U,$J,358.3,9616,1,4,0)
 ;;=4^854.12
 ;;^UTILITY(U,$J,358.3,9616,2)
 ;;=^274722
 ;;^UTILITY(U,$J,358.3,9617,0)
 ;;=854.13^^63^614^115
 ;;^UTILITY(U,$J,358.3,9617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9617,1,3,0)
 ;;=3^TBI-Closed,LOC 1-24hr
 ;;^UTILITY(U,$J,358.3,9617,1,4,0)
 ;;=4^854.13
 ;;^UTILITY(U,$J,358.3,9617,2)
 ;;=^274723
 ;;^UTILITY(U,$J,358.3,9618,0)
 ;;=854.14^^63^614^116
 ;;^UTILITY(U,$J,358.3,9618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9618,1,3,0)
 ;;=3^TBI-Closed,LOC > 24hr
 ;;^UTILITY(U,$J,358.3,9618,1,4,0)
 ;;=4^854.14
 ;;^UTILITY(U,$J,358.3,9618,2)
 ;;=^274724
 ;;^UTILITY(U,$J,358.3,9619,0)
 ;;=908.3^^63^614^17
 ;;^UTILITY(U,$J,358.3,9619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9619,1,3,0)
 ;;=3^Carotid Cavernous Fistula,Late Effect
 ;;^UTILITY(U,$J,358.3,9619,1,4,0)
 ;;=4^908.3
 ;;^UTILITY(U,$J,358.3,9619,2)
 ;;=^275249
 ;;^UTILITY(U,$J,358.3,9620,0)
 ;;=368.2^^63^615^24
 ;;^UTILITY(U,$J,358.3,9620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9620,1,3,0)
 ;;=3^Diplopia
 ;;^UTILITY(U,$J,358.3,9620,1,4,0)
 ;;=4^368.2
 ;;^UTILITY(U,$J,358.3,9620,2)
 ;;=^35208
 ;;^UTILITY(U,$J,358.3,9621,0)
 ;;=695.3^^63^615^2
 ;;^UTILITY(U,$J,358.3,9621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9621,1,3,0)
 ;;=3^Acne Rosacea
 ;;^UTILITY(U,$J,358.3,9621,1,4,0)
 ;;=4^695.3
 ;;^UTILITY(U,$J,358.3,9621,2)
 ;;=Acne Rosacea^107114
 ;;^UTILITY(U,$J,358.3,9622,0)
 ;;=250.00^^63^615^22
 ;;^UTILITY(U,$J,358.3,9622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9622,1,3,0)
 ;;=3^DM type II w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,9622,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,9622,2)
 ;;=DM type II w/o Eye Disease^33605
 ;;^UTILITY(U,$J,358.3,9623,0)
 ;;=346.90^^63^615^41
 ;;^UTILITY(U,$J,358.3,9623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9623,1,3,0)
 ;;=3^Headache,Migraine-Not Intractable
 ;;^UTILITY(U,$J,358.3,9623,1,4,0)
 ;;=4^346.90
 ;;^UTILITY(U,$J,358.3,9623,2)
 ;;=Migraine without Intract^293880
 ;;^UTILITY(U,$J,358.3,9624,0)
 ;;=376.30^^63^615^30
 ;;^UTILITY(U,$J,358.3,9624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9624,1,3,0)
 ;;=3^Exophthalmos,NOS
 ;;^UTILITY(U,$J,358.3,9624,1,4,0)
 ;;=4^376.30
 ;;^UTILITY(U,$J,358.3,9624,2)
 ;;=Exophthalmos NOS^43683
 ;;^UTILITY(U,$J,358.3,9625,0)
 ;;=368.8^^63^615^7
 ;;^UTILITY(U,$J,358.3,9625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9625,1,3,0)
 ;;=3^Blurred Vision
 ;;^UTILITY(U,$J,358.3,9625,1,4,0)
 ;;=4^368.8
 ;;^UTILITY(U,$J,358.3,9625,2)
 ;;=Blurred Vision^88172
 ;;^UTILITY(U,$J,358.3,9626,0)
 ;;=362.34^^63^615^5
 ;;^UTILITY(U,$J,358.3,9626,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9626,1,3,0)
 ;;=3^Amaurosis Fugax
 ;;^UTILITY(U,$J,358.3,9626,1,4,0)
 ;;=4^362.34
 ;;^UTILITY(U,$J,358.3,9626,2)
 ;;=^268622
 ;;^UTILITY(U,$J,358.3,9627,0)
 ;;=368.13^^63^615^87
 ;;^UTILITY(U,$J,358.3,9627,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9627,1,3,0)
 ;;=3^Photophobia
 ;;^UTILITY(U,$J,358.3,9627,1,4,0)
 ;;=4^368.13
 ;;^UTILITY(U,$J,358.3,9627,2)
 ;;=^126851
 ;;^UTILITY(U,$J,358.3,9628,0)
 ;;=368.40^^63^615^112
 ;;^UTILITY(U,$J,358.3,9628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9628,1,3,0)
 ;;=3^Vis Field Defect
 ;;^UTILITY(U,$J,358.3,9628,1,4,0)
 ;;=4^368.40
 ;;^UTILITY(U,$J,358.3,9628,2)
 ;;=^126859
 ;;^UTILITY(U,$J,358.3,9629,0)
 ;;=369.4^^63^615^58
 ;;^UTILITY(U,$J,358.3,9629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9629,1,3,0)
 ;;=3^Legally Blind,USA Definition
 ;;^UTILITY(U,$J,358.3,9629,1,4,0)
 ;;=4^369.4
 ;;^UTILITY(U,$J,358.3,9629,2)
 ;;=Legal Blindness^268887
 ;;^UTILITY(U,$J,358.3,9630,0)
 ;;=250.01^^63^615^21
 ;;^UTILITY(U,$J,358.3,9630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9630,1,3,0)
 ;;=3^DM Type I w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,9630,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,9630,2)
 ;;=Diabetes Mellitus Type I^33586
 ;;^UTILITY(U,$J,358.3,9631,0)
 ;;=V08.^^63^615^40
 ;;^UTILITY(U,$J,358.3,9631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9631,1,3,0)
 ;;=3^HIV Positive
 ;;^UTILITY(U,$J,358.3,9631,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,9631,2)
 ;;=Asymptomatic HIV Status^303392
 ;;^UTILITY(U,$J,358.3,9632,0)
 ;;=921.0^^63^615^16
 ;;^UTILITY(U,$J,358.3,9632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9632,1,3,0)
 ;;=3^Contusion of Eye
 ;;^UTILITY(U,$J,358.3,9632,1,4,0)
 ;;=4^921.0
 ;;^UTILITY(U,$J,358.3,9632,2)
 ;;=^15052
 ;;^UTILITY(U,$J,358.3,9633,0)
 ;;=379.91^^63^615^86
 ;;^UTILITY(U,$J,358.3,9633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9633,1,3,0)
 ;;=3^Pain in/around the Eye
 ;;^UTILITY(U,$J,358.3,9633,1,4,0)
 ;;=4^379.91
 ;;^UTILITY(U,$J,358.3,9633,2)
 ;;=Pain in or around eye^89093
 ;;^UTILITY(U,$J,358.3,9634,0)
 ;;=V58.69^^63^615^44
 ;;^UTILITY(U,$J,358.3,9634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9634,1,3,0)
 ;;=3^Hi-Risk Med,Long Term Current Use
 ;;^UTILITY(U,$J,358.3,9634,1,4,0)
 ;;=4^V58.69
 ;;^UTILITY(U,$J,358.3,9634,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,9635,0)
 ;;=871.4^^63^615^54
 ;;^UTILITY(U,$J,358.3,9635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9635,1,3,0)
 ;;=3^Laceration of Eyeball
 ;;^UTILITY(U,$J,358.3,9635,1,4,0)
 ;;=4^871.4
 ;;^UTILITY(U,$J,358.3,9635,2)
 ;;=Laceration of Eyeball^274889
 ;;^UTILITY(U,$J,358.3,9636,0)
 ;;=242.90^^63^615^107
 ;;^UTILITY(U,$J,358.3,9636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9636,1,3,0)
 ;;=3^Thyroid Eye Dis
 ;;^UTILITY(U,$J,358.3,9636,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,9636,2)
 ;;=Thyroid Eye Dis^267811^376.21
 ;;^UTILITY(U,$J,358.3,9637,0)
 ;;=135.^^63^615^100
 ;;^UTILITY(U,$J,358.3,9637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9637,1,3,0)
 ;;=3^Sarcoidosis
 ;;^UTILITY(U,$J,358.3,9637,1,4,0)
 ;;=4^135.
 ;;^UTILITY(U,$J,358.3,9637,2)
 ;;=Sarcoidosis^107916
 ;;^UTILITY(U,$J,358.3,9638,0)
 ;;=446.5^^63^615^106
 ;;^UTILITY(U,$J,358.3,9638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9638,1,3,0)
 ;;=3^Temporal Arteritis
 ;;^UTILITY(U,$J,358.3,9638,1,4,0)
 ;;=4^446.5
 ;;^UTILITY(U,$J,358.3,9638,2)
 ;;=Temporal Arteritis^117658
 ;;^UTILITY(U,$J,358.3,9639,0)
 ;;=401.9^^63^615^49
 ;;^UTILITY(U,$J,358.3,9639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9639,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,9639,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,9639,2)
 ;;=Hypertension^186630
 ;;^UTILITY(U,$J,358.3,9640,0)
 ;;=V72.0^^63^615^32
 ;;^UTILITY(U,$J,358.3,9640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9640,1,3,0)
 ;;=3^Eye Exam
 ;;^UTILITY(U,$J,358.3,9640,1,4,0)
 ;;=4^V72.0
 ;;^UTILITY(U,$J,358.3,9640,2)
 ;;=Eye Exam^43432
 ;;^UTILITY(U,$J,358.3,9641,0)
 ;;=V41.0^^63^615^90
 ;;^UTILITY(U,$J,358.3,9641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9641,1,3,0)
 ;;=3^Problems with Sight
 ;;^UTILITY(U,$J,358.3,9641,1,4,0)
 ;;=4^V41.0
 ;;^UTILITY(U,$J,358.3,9641,2)
 ;;=^295427
 ;;^UTILITY(U,$J,358.3,9642,0)
 ;;=998.59^^63^615^88
 ;;^UTILITY(U,$J,358.3,9642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9642,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,9642,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,9642,2)
 ;;=Post Op Infection^97081
 ;;^UTILITY(U,$J,358.3,9643,0)
 ;;=042.^^63^615^1
 ;;^UTILITY(U,$J,358.3,9643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9643,1,3,0)
 ;;=3^AIDS,Unspec
 ;;^UTILITY(U,$J,358.3,9643,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,9643,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,9644,0)
 ;;=053.29^^63^615^43
 ;;^UTILITY(U,$J,358.3,9644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9644,1,3,0)
 ;;=3^Herpes Zoster,Oth
 ;;^UTILITY(U,$J,358.3,9644,1,4,0)
 ;;=4^053.29
 ;;^UTILITY(U,$J,358.3,9644,2)
 ;;=^266555
 ;;^UTILITY(U,$J,358.3,9645,0)
 ;;=054.40^^63^615^42
 ;;^UTILITY(U,$J,358.3,9645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9645,1,3,0)
 ;;=3^Herpes Simplex
 ;;^UTILITY(U,$J,358.3,9645,1,4,0)
 ;;=4^054.40
 ;;^UTILITY(U,$J,358.3,9645,2)
 ;;=^266562
 ;;^UTILITY(U,$J,358.3,9646,0)
 ;;=190.1^^63^615^82
 ;;^UTILITY(U,$J,358.3,9646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9646,1,3,0)
 ;;=3^Orbit Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,9646,1,4,0)
 ;;=4^190.1
 ;;^UTILITY(U,$J,358.3,9646,2)
 ;;=^267272
 ;;^UTILITY(U,$J,358.3,9647,0)
 ;;=190.2^^63^615^50
 ;;^UTILITY(U,$J,358.3,9647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9647,1,3,0)
 ;;=3^Lac Gland Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,9647,1,4,0)
 ;;=4^190.2
 ;;^UTILITY(U,$J,358.3,9647,2)
 ;;=^267273
 ;;^UTILITY(U,$J,358.3,9648,0)
 ;;=190.7^^63^615^52
 ;;^UTILITY(U,$J,358.3,9648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9648,1,3,0)
 ;;=3^Lac Sac Nasolac Malig Neoplasm
